AAAAAA
Results: 26-50/77
Authors:
BATIUK TD
URMSON J
VINCENT D
YATSCOFF RW
HALLORAN PF
Citation: Td. Batiuk et al., QUANTITATING IMMUNOSUPPRESSION - ESTIMATING THE 50-PERCENT INHIBITORYCONCENTRATION FOR IN-VIVO CYCLOSPORINE IN MICE, Transplantation, 61(11), 1996, pp. 1618-1624
Authors:
LANGMAN LJ
SHAPIRO AMJ
LAKEY JRT
LEGATT DF
KNETEMAN NM
YATSCOFF RW
Citation: Lj. Langman et al., PHARMACODYNAMIC ASSESSMENT OF MYCOPHENOLIC ACID-INDUCED IMMUNOSUPPRESSION BY MEASUREMENT OF INOSINE MONOPHOSPHATE DEHYDROGENASE-ACTIVITY INA CANINE MODEL, Transplantation, 61(1), 1996, pp. 87-92
Authors:
DIAS VC
MADSEN KL
WONG J
DORING K
KEELAN M
THOMSON ABR
YATSCOFF RW
Citation: Vc. Dias et al., ORAL-ADMINISTRATION OF RAPAMYCIN AND CYCLOSPORINE DIFFERENTIALLY ALTER INTESTINAL D-GLUCOSE UPTAKE AND INSULIN PERMEABILITY IN RABBITS, Gastroenterology, 110(4), 1996, pp. 798-798
Authors:
ASPESLET LJ
LEGATT DF
YATSCOFF RW
Citation: Lj. Aspeslet et al., EFFECT OF ASSAY METHODOLOGY ON PHARMACOKINETIC DIFFERENCES BETWEEN CYCLOSPORINE NEORAL AND SANDIMMUNE FORMULATIONS, Clinical chemistry, 42(6), 1996, pp. 482-482
Authors:
GOODYEAR N
MURTHY JN
GALLANT HL
YATSCOFF RW
SOLDIN SJ
Citation: N. Goodyear et al., COMPARISON OF BINDING CHARACTERISTICS OF 4 RAPAMYCIN METABOLITES TO THE 14-KDA AND 52-KDA IMMUNOPHILINS TO THEIR PHARMACOLOGICAL ACTIVITY AS MEASURED IN THE MIXED LYMPHOCYTE CULTURE ASSAY, Clinical chemistry, 42(6), 1996, pp. 492-492
Authors:
ASPESLET L
YATSCOFF RW
CHAPELSKY L
MORRISH D
Citation: L. Aspeslet et al., ANALYTICAL AND CLINICAL-EVALUATION OF AN AUTOMATED TESTOSTERONE ASSAYON THE ACS-180, Clinical chemistry, 42(6), 1996, pp. 560-560
Authors:
ASPESLET L
YATSCOFF RW
CHAPELSKY L
MORRISH D
Citation: L. Aspeslet et al., ANALYTICAL AND CLINICAL-EVALUATION OF AN AUTOMATED CORTISOL ASSAY ON THE ACS-180, Clinical chemistry, 42(6), 1996, pp. 561-561
Authors:
GOODYEAR N
MURTHY JN
GALLANT HL
YATSCOFF RW
SOLDIN SJ
Citation: N. Goodyear et al., COMPARISON OF BINDING CHARACTERISTICS OF 4 RAPAMYCIN METABOLITES TO THE 14 AND 52 KDA IMMUNOPHILINS WITH THEIR PHARMACOLOGICAL ACTIVITY MEASURED BY THE MIXED-LYMPHOCYTE CULTURE ASSAY, Clinical biochemistry, 29(4), 1996, pp. 309-313
Authors:
YATSCOFF RW
CHAPELSKY L
MORRISH D
Citation: Rw. Yatscoff et al., ANALYTICAL AND CLINICAL-EVALUATION OF AN AUTOMATED CORTISOL ASSAY ON THE ACS-180(R), Clinical biochemistry, 29(4), 1996, pp. 315-319
Authors:
DIAS VC
MOSCHOPEDIS T
PROSSER C
YATSCOFF RW
Citation: Vc. Dias et al., EVALUATION OF THE CLINITEK(R) ATLAS(TM) FOR ROUTINE MACROSCOPIC URINALYSIS, Clinical biochemistry, 29(3), 1996, pp. 217-223
Authors:
DIAS VC
YATSCOFF RW
Citation: Vc. Dias et Rw. Yatscoff, AN IN-VITRO METHOD FOR PREDICTING IN-VIVO ORAL BIOAVAILABILITY OF NOVEL IMMUNOSUPPRESSIVE DRUGS, Clinical biochemistry, 29(1), 1996, pp. 43-49
Authors:
PILARSKI LM
YATSCOFF RW
MURPHY GF
BELCH AR
Citation: Lm. Pilarski et al., CYCLOSPORINE ANALOGS AND METABOLITES AS CHEMOSENSITIZERS IN MULTIPLE-MYELOMA - DIFFERENTIAL DRUG AND DYE RETENTION BY CIRCULATING B-CELLS AS COMPARED TO BONE-MARROW PLASMA-CELLS, Blood, 88(10), 1996, pp. 1546-1546
Authors:
KOBRINSKY NL
YAGER JY
CHEANG MS
YATSCOFF RW
TENENBEIN M
Citation: Nl. Kobrinsky et al., DOES IRON-DEFICIENCY RAISE THE SEIZURE THRESHOLD, Journal of child neurology, 10(2), 1995, pp. 105-109
Authors:
THLIVERIS JA
SOLEZ K
YATSCOFF RW
Citation: Ja. Thliveris et al., A COMPARISON OF THE EFFECTS OF RAPAMYCIN AND CYCLOSPORINE ON KIDNEY AND HEART MORPHOLOGY IN A RABBIT HETEROTOPIC HEART-TRANSPLANT MODEL, Histology and histopathology, 10(2), 1995, pp. 417-421
Authors:
SOLDIN SJ
SHAW LM
YATSCOFF RW
Citation: Sj. Soldin et al., PROCEEDINGS OF THE INTERNATIONAL CONSENSUS CONFERENCE ON IMMUNOSUPPRESSIVE DRUGS - LAKE-LOUISE, ALBERTA, CANADA - MAY 5-7, 1995, Therapeutic drug monitoring, 17(6), 1995, pp. 559-559
Authors:
YATSCOFF RW
LANGMAN L
LEGATT DF
Citation: Rw. Yatscoff et al., THERAPEUTIC DRUG-MONITORING OF CYCLOSPORINE-G, Therapeutic drug monitoring, 17(6), 1995, pp. 655-659
Authors:
YATSCOFF RW
WANG P
CHAN K
HICKS D
ZIMMERMAN J
Citation: Rw. Yatscoff et al., RAPAMYCIN - DISTRIBUTION, PHARMACOKINETICS, AND THERAPEUTIC RANGE INVESTIGATIONS, Therapeutic drug monitoring, 17(6), 1995, pp. 666-671
Authors:
YATSCOFF RW
BOECKX R
HOLT DW
KAHAN BD
LEGATT DF
SEHGAL S
SOLDIN SJ
NAPOLI K
STILLER C
Citation: Rw. Yatscoff et al., CONSENSUS GUIDELINES FOR THERAPEUTIC DRUG-MONITORING OF RAPAMYCIN - REPORT OF THE CONSENSUS PANEL, Therapeutic drug monitoring, 17(6), 1995, pp. 676-680
Authors:
SHAW LM
SOLLINGER HW
HALLORAN P
MORRIS RE
YATSCOFF RW
RANSOM J
TSINA I
KEOWN P
HOLT DW
LIEBERMAN R
JAKLITSCH A
POTTER J
Citation: Lm. Shaw et al., MYCOPHENOLATE MOFETIL - A REPORT OF THE CONSENSUS PANEL, Therapeutic drug monitoring, 17(6), 1995, pp. 690-699
Authors:
LUCIEN J
DIAS VC
LEGATT DF
YATSCOFF RW
Citation: J. Lucien et al., BLOOD DISTRIBUTION AND SINGLE-DOSE PHARMACOKINETICS OF LEFLUNOMIDE, Therapeutic drug monitoring, 17(5), 1995, pp. 454-459
Authors:
YATSCOFF RW
CHACKOWSKY P
Citation: Rw. Yatscoff et P. Chackowsky, QUALITY ASSURANCE PROGRAM FOR CYCLOSPORINE-G (OG37-325), Therapeutic drug monitoring, 17(4), 1995, pp. 342-347
Authors:
DIAS VC
LUCIEN J
LEGATT DF
YATSCOFF RW
Citation: Vc. Dias et al., MEASUREMENT OF THE ACTIVE LEFLUNOMIDE METABOLITE-(A77-1726) BY REVERSE-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Therapeutic drug monitoring, 17(1), 1995, pp. 84-88
Authors:
THLIVERIS JA
YATSCOFF RW
Citation: Ja. Thliveris et Rw. Yatscoff, EFFECT OF RAPAMYCIN ON MORPHOLOGICAL AND FUNCTIONAL, PARAMETERS IN THE KIDNEY OF THE RABBIT, Transplantation, 59(3), 1995, pp. 427-429
Authors:
LI SU
YATSCOFF RW
BLACK K
PETER JB
Citation: Su. Li et al., IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF CYCLOSPORINE-A IN WHOLE-BLOOD, Clinical chemistry, 41(6), 1995, pp. 125-126
Authors:
MOCK T
YATSCOFF RW
Citation: T. Mock et Rw. Yatscoff, AN EVALUATION OF BLOOD-GAS AND IONIZED CALCIUM MEASUREMENT OF THE I-STAT ANALYZER, Clinical chemistry, 41(6), 1995, pp. 182-182